Search Results: keywords:"pharmaceutical innovation"

  • S. 5573 — To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
    Status:Introduced in Senate
    Words:1,137

    S. 5573 aims to change title 35 of the United States Code to create a "safe harbor" that protects certain actions from being considered patent infringement. Specifically, it protects companies that apply to sell generic or biosimilar versions of drugs or biological products...

    Simple Explanation

    The bill wants to make it okay for companies to sell cheaper versions of medicines without getting in trouble for using someone else's idea, as long as they don't copy certain special uses from the original. It also wants this rule to work for things done before, now, or in the future.

  • H. R. 1672 — To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
    Status:Introduced in House
    Words:407

    H. R. 1672, titled the "Maintaining Investments in New Innovation Act," is proposed to amend the Social Security Act. It aims to protect access to genetically targeted technologies by changing how certain drug products are classified. This includes redefining qualifying single-source drugs by...

    Simple Explanation

    H.R. 1672 is a rule that aims to help drug makers keep their special rights to sell new, genetically-targeted medicines for a longer time, which could help them make more money but might also mean these medicines stay pricey for a bit longer.